Search ResultsElectronic Resources
Limit Search Results
Author
Material Type
Language
Subject
Library
51 Results Found Subscribe to search results
000000000000DEFAULT
Print
Select a list
Make this your default list.
The following items were successfully added.
    There was an error while adding the following items. Please try again.
      by 
      McKay, Gerard A.
      Format: 
      Excerpt: 
      reproductive system -- Drugs and the urological system -- Cancer therapeutics -- Drugs and inflammatory joint
      by 
      August, J. Thomas.
      Format: 
      Excerpt: 
      Colorectal Cancer and Nonsteroidal Anti-inflammatory Drugs -- Mouse Mammary Tumor Virus and the
      by 
      Testa, Bernard.
      Format: 
      Excerpt: 
      .E. Kane, Multidrug Resistance of Cancer Cells. -- H. Schroder, Bioactivation of Organic Nitrates and Other
      by 
      August, J. Thomas.
      Format: 
      Excerpt: 
      Cancer -- Reversal of atherosclerosis with therapy: Update of coronary angiographic trials -- Unnatural
      by 
      Anders, M. W. (Marion Walter), 1936-
      Format: 
      Excerpt: 
      in the Chemoprevention of Cancer; lmmunoconjugates and lmmunotoxins for Therapy of Carcinomas
      by 
      August, J. Thomas.
      Format: 
      Excerpt: 
      ; Activation and Inactivation of Gene Expression Using RNA Sequences; Therapy of Cancer Metastasis by Systemic
      by 
      Ellis, G. P.
      Format: 
      Excerpt: 
      Inhibition as a Potential Treatment for Oestrogen-Dependent Breast Cancer; Chapter 3. Endocrine Treatment of
      by 
      Gurol, Kerem Cahit, author.
      Format: 
      Excerpt: 
      NMS-873 inhibit necroptosis in human colorectal cancer HT-29 cells. VCP inhibition clearly changes the
      by 
      Whitmore, Aurellia M., author.
      Format: 
      Excerpt: 
      protection of cells from cytotoxic stress and may serve as targets to hypersensitize cells to cancer therapy
      by 
      Suarez Del Pino, Jose Antonio, author.
      Format: 
      Excerpt: 
      prostate cancer. However, several HSP90 inhibitors including SNX5422 were removed from cancer clinical
      by 
      Enna, S. J.
      Format: 
      Excerpt: 
      pharmacology of proteasome inhibitors for the management and treatment of cancer / Bruce Ruggeri [and others